Selected research
Industry Research
Digital Pathology Services Industry Research Report 2026
Market perspective
The global Digital Pathology Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Pathology Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Pathology Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Pathology Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Pathology Services include Roche, Leica Biosystems, Philips, Charles River Laboratories, Olympus, ZEISS, Visiopharm, Sectra and Proscia, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Pathology Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Pathology Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Pathology Services Market by Company
Roche
Leica Biosystems
Philips
Charles River Laboratories
Olympus
ZEISS
Visiopharm
Sectra
Proscia
Pathomation
PathAI
OptraScan
Media Cybernetics
Inotiv
Indica Labs
Hamamatsu Photonics
Gestalt
Digital Slide Archive
Aiforia
Digital Pathology Services Segment by Type
Cytopathology
Histopathology
Other
Digital Pathology Services Segment by Application
Diagnostic Centers
Hospital
Laboratories & Research Institutes
Digital Pathology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Pathology Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cytopathology
- Histopathology
- Other
Applications
- Diagnostic Centers
- Hospital
- Laboratories & Research Institutes
Companies covered
- Roche
- Leica Biosystems
- Philips
- Charles River Laboratories
- Olympus
- ZEISS
- Visiopharm
- Sectra
- Proscia
- Pathomation
- PathAI
- OptraScan
- Media Cybernetics
- Inotiv
- Indica Labs
- Hamamatsu Photonics
- Gestalt
- Digital Slide Archive
- Aiforia
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Pathology Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cytopathology
- 2.2.3 Histopathology
- 2.2.4 Other
- 2.3 Digital Pathology Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic Centers
- 2.3.3 Hospital
- 2.3.4 Laboratories & Research Institutes
- 2.4 Assumptions and Limitations
3 Digital Pathology Services Breakdown Data by Type
- 3.1 Global Digital Pathology Services Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Pathology Services Forecasted Market Size by Type (2027-2032)
4 Digital Pathology Services Breakdown Data by Application
- 4.1 Global Digital Pathology Services Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Pathology Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Pathology Services Market Perspective (2021-2032)
- 5.2 Global Digital Pathology Services Growth Trends by Region
- 5.2.1 Global Digital Pathology Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Pathology Services Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Pathology Services Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Pathology Services Market Dynamics
- 5.3.1 Digital Pathology Services Industry Trends
- 5.3.2 Digital Pathology Services Market Drivers
- 5.3.3 Digital Pathology Services Market Challenges
- 5.3.4 Digital Pathology Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Pathology Services Players by Revenue
- 6.1.1 Global Top Digital Pathology Services Players by Revenue (2021-2026)
- 6.1.2 Global Digital Pathology Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Pathology Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Pathology Services Head Office and Area Served
- 6.4 Global Digital Pathology Services Players, Product Type & Application
- 6.5 Global Digital Pathology Services Manufacturers Established Date
- 6.6 Global Digital Pathology Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Pathology Services Market Size (2021-2032)
- 7.2 North America Digital Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Pathology Services Market Size by Country (2021-2026)
- 7.4 North America Digital Pathology Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Pathology Services Market Size (2021-2032)
- 8.2 Europe Digital Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Pathology Services Market Size by Country (2021-2026)
- 8.4 Europe Digital Pathology Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Pathology Services Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Pathology Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Pathology Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Pathology Services Market Size (2021-2032)
- 10.2 South America Digital Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Pathology Services Market Size by Country (2021-2026)
- 10.4 South America Digital Pathology Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Pathology Services Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Pathology Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Pathology Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Digital Pathology Services Business (2021-2026)
- 12.1.4 Roche Digital Pathology Services Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Leica Biosystems
- 12.2.1 Leica Biosystems Company Information
- 12.2.2 Leica Biosystems Business Overview
- 12.2.3 Leica Biosystems Revenue in Digital Pathology Services Business (2021-2026)
- 12.2.4 Leica Biosystems Digital Pathology Services Product Portfolio
- 12.2.5 Leica Biosystems Recent Developments
- 12.3 Philips
- 12.3.1 Philips Company Information
- 12.3.2 Philips Business Overview
- 12.3.3 Philips Revenue in Digital Pathology Services Business (2021-2026)
- 12.3.4 Philips Digital Pathology Services Product Portfolio
- 12.3.5 Philips Recent Developments
- 12.4 Charles River Laboratories
- 12.4.1 Charles River Laboratories Company Information
- 12.4.2 Charles River Laboratories Business Overview
- 12.4.3 Charles River Laboratories Revenue in Digital Pathology Services Business (2021-2026)
- 12.4.4 Charles River Laboratories Digital Pathology Services Product Portfolio
- 12.4.5 Charles River Laboratories Recent Developments
- 12.5 Olympus
- 12.5.1 Olympus Company Information
- 12.5.2 Olympus Business Overview
- 12.5.3 Olympus Revenue in Digital Pathology Services Business (2021-2026)
- 12.5.4 Olympus Digital Pathology Services Product Portfolio
- 12.5.5 Olympus Recent Developments
- 12.6 ZEISS
- 12.6.1 ZEISS Company Information
- 12.6.2 ZEISS Business Overview
- 12.6.3 ZEISS Revenue in Digital Pathology Services Business (2021-2026)
- 12.6.4 ZEISS Digital Pathology Services Product Portfolio
- 12.6.5 ZEISS Recent Developments
- 12.7 Visiopharm
- 12.7.1 Visiopharm Company Information
- 12.7.2 Visiopharm Business Overview
- 12.7.3 Visiopharm Revenue in Digital Pathology Services Business (2021-2026)
- 12.7.4 Visiopharm Digital Pathology Services Product Portfolio
- 12.7.5 Visiopharm Recent Developments
- 12.8 Sectra
- 12.8.1 Sectra Company Information
- 12.8.2 Sectra Business Overview
- 12.8.3 Sectra Revenue in Digital Pathology Services Business (2021-2026)
- 12.8.4 Sectra Digital Pathology Services Product Portfolio
- 12.8.5 Sectra Recent Developments
- 12.9 Proscia
- 12.9.1 Proscia Company Information
- 12.9.2 Proscia Business Overview
- 12.9.3 Proscia Revenue in Digital Pathology Services Business (2021-2026)
- 12.9.4 Proscia Digital Pathology Services Product Portfolio
- 12.9.5 Proscia Recent Developments
- 12.10 Pathomation
- 12.10.1 Pathomation Company Information
- 12.10.2 Pathomation Business Overview
- 12.10.3 Pathomation Revenue in Digital Pathology Services Business (2021-2026)
- 12.10.4 Pathomation Digital Pathology Services Product Portfolio
- 12.10.5 Pathomation Recent Developments
- 12.11 PathAI
- 12.11.1 PathAI Company Information
- 12.11.2 PathAI Business Overview
- 12.11.3 PathAI Revenue in Digital Pathology Services Business (2021-2026)
- 12.11.4 PathAI Digital Pathology Services Product Portfolio
- 12.11.5 PathAI Recent Developments
- 12.12 OptraScan
- 12.12.1 OptraScan Company Information
- 12.12.2 OptraScan Business Overview
- 12.12.3 OptraScan Revenue in Digital Pathology Services Business (2021-2026)
- 12.12.4 OptraScan Digital Pathology Services Product Portfolio
- 12.12.5 OptraScan Recent Developments
- 12.13 Media Cybernetics
- 12.13.1 Media Cybernetics Company Information
- 12.13.2 Media Cybernetics Business Overview
- 12.13.3 Media Cybernetics Revenue in Digital Pathology Services Business (2021-2026)
- 12.13.4 Media Cybernetics Digital Pathology Services Product Portfolio
- 12.13.5 Media Cybernetics Recent Developments
- 12.14 Inotiv
- 12.14.1 Inotiv Company Information
- 12.14.2 Inotiv Business Overview
- 12.14.3 Inotiv Revenue in Digital Pathology Services Business (2021-2026)
- 12.14.4 Inotiv Digital Pathology Services Product Portfolio
- 12.14.5 Inotiv Recent Developments
- 12.15 Indica Labs
- 12.15.1 Indica Labs Company Information
- 12.15.2 Indica Labs Business Overview
- 12.15.3 Indica Labs Revenue in Digital Pathology Services Business (2021-2026)
- 12.15.4 Indica Labs Digital Pathology Services Product Portfolio
- 12.15.5 Indica Labs Recent Developments
- 12.16 Hamamatsu Photonics
- 12.16.1 Hamamatsu Photonics Company Information
- 12.16.2 Hamamatsu Photonics Business Overview
- 12.16.3 Hamamatsu Photonics Revenue in Digital Pathology Services Business (2021-2026)
- 12.16.4 Hamamatsu Photonics Digital Pathology Services Product Portfolio
- 12.16.5 Hamamatsu Photonics Recent Developments
- 12.17 Gestalt
- 12.17.1 Gestalt Company Information
- 12.17.2 Gestalt Business Overview
- 12.17.3 Gestalt Revenue in Digital Pathology Services Business (2021-2026)
- 12.17.4 Gestalt Digital Pathology Services Product Portfolio
- 12.17.5 Gestalt Recent Developments
- 12.18 Digital Slide Archive
- 12.18.1 Digital Slide Archive Company Information
- 12.18.2 Digital Slide Archive Business Overview
- 12.18.3 Digital Slide Archive Revenue in Digital Pathology Services Business (2021-2026)
- 12.18.4 Digital Slide Archive Digital Pathology Services Product Portfolio
- 12.18.5 Digital Slide Archive Recent Developments
- 12.19 Aiforia
- 12.19.1 Aiforia Company Information
- 12.19.2 Aiforia Business Overview
- 12.19.3 Aiforia Revenue in Digital Pathology Services Business (2021-2026)
- 12.19.4 Aiforia Digital Pathology Services Product Portfolio
- 12.19.5 Aiforia Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst